BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31462154)

  • 1. Design and evaluation of topical solid dispersion composite of voriconazole for the treatment of ocular keratitis.
    Patil M; Waydande S; Pawar P
    Ther Deliv; 2019 Aug; 10(8):481-492. PubMed ID: 31462154
    [No Abstract]   [Full Text] [Related]  

  • 2. Ocular Inserts of Voriconazole-Loaded Proniosomal Gels: Formulation, Evaluation and Microbiological Studies.
    El-Emam GA; Girgis GNS; El-Sokkary MMA; El-Azeem Soliman OA; Abd El Gawad AEGH
    Int J Nanomedicine; 2020; 15():7825-7840. PubMed ID: 33116503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole-Cyclodextrin Supramolecular Ternary Complex-Loaded Ocular Films for Management of Fungal Keratitis.
    Suvarna P; Chaudhari P; Birangal S; Mallela LS; Roy S; Koteshwara A; Aranjani JM; Lewis SA
    Mol Pharm; 2022 Jan; 19(1):258-273. PubMed ID: 34928610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
    Dhumal RS; Biradar SV; Aher S; Paradkar AR
    J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
    Shinde VR; Shelake MR; Shetty SS; Chavan-Patil AB; Pore YV; Late SG
    J Pharm Pharmacol; 2008 Sep; 60(9):1121-9. PubMed ID: 18718114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
    Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
    Ruan LP; Yu BY; Fu GM; Zhu DN
    J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
    Thenmozhi K; Yoo YJ
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical characterization of gliclazide-macrogol solid dispersion and tablets based on optimized dispersion.
    Khattab IS; Nada A; Zaghloul AA
    Drug Dev Ind Pharm; 2010 Aug; 36(8):893-902. PubMed ID: 20196643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the dissolution profile of allopurinol by a solid dispersion technique.
    Samy AM; Marzouk MA; Ammar AA; Ahmed MK
    Drug Discov Ther; 2010 Apr; 4(2):77-84. PubMed ID: 22491164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of solid dispersion systems in hydrophilic carriers to increase benzonidazole solubility.
    Lima AA; Soares-Sobrinho JL; Silva JL; Corrêa-Júnior RA; Lyra MA; Santos FL; Oliveira BG; Hernandes MZ; Rolim LA; Rolim-Neto PJ
    J Pharm Sci; 2011 Jun; 100(6):2443-51. PubMed ID: 21491453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
    Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
    Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate.
    Thongnopkoon T; Puttipipatkhachorn S
    Drug Dev Ind Pharm; 2016 Jan; 42(1):70-79. PubMed ID: 25835067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evaluation of HP-β-CD based voriconazole formulations for ocular drug delivery.
    Pahuja P; Kashyap H; Pawar P
    Curr Drug Deliv; 2014; 11(2):223-32. PubMed ID: 24365062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.
    Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
    Drug Dev Ind Pharm; 2015 May; 41(5):772-9. PubMed ID: 24669978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ forming and mucoadhesive ophthalmic voriconazole/HPβCD hydrogels for the treatment of fungal keratitis.
    Díaz-Tomé V; García-Otero X; Varela-Fernández R; Martín-Pastor M; Conde-Penedo A; Aguiar P; González-Barcia M; Fernández-Ferreiro A; Otero-Espinar FJ
    Int J Pharm; 2021 Mar; 597():120318. PubMed ID: 33540021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of the voriconazole loaded lipid-based nanoparticles.
    Füredi P; Pápay ZE; Kovács K; Kiss BD; Ludányi K; Antal I; Klebovich I
    J Pharm Biomed Anal; 2017 Jan; 132():184-189. PubMed ID: 27750101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
    Patel RP; Patel MM
    Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.